Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance - PubMed (original) (raw)
. 1998 May 15;160(10):4719-29.
Affiliations
- PMID: 9590217
Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance
K A Pape et al. J Immunol. 1998.
Abstract
A small population of CD4+ OVA-specific TCR transgenic T cells was tracked following the induction of peripheral tolerance by soluble Ag to address whether functionally unresponsive, or anergic T cells, persist in vivo for extended periods of time. Although injection of OVA peptide in the absence of adjuvant caused a transient expansion and deletion of the Ag-specific T cells, a population that showed signs of prior activation persisted in the lymphoid tissues for several months. These surviving OVA-specific T cells had long-lasting, but reversible defects in their ability to proliferate in lymph nodes and secrete IL-2 and TNF-alpha in vivo following an antigenic challenge. These defects were not associated with the production of Th2-type cytokines or the capacity to suppress the clonal expansion of a bystander population of T cells present in the same lymph nodes. Therefore, our results provide direct evidence that a long-lived population of functionally impaired Ag-specific CD4+ T cells is generated in vivo after exposure to soluble Ag.
Similar articles
- Antigen-specific T cell activation and proliferation during oral tolerance induction.
Sun J, Dirden-Kramer B, Ito K, Ernst PB, Van Houten N. Sun J, et al. J Immunol. 1999 May 15;162(10):5868-75. J Immunol. 1999. PMID: 10229822 - Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
Sun JB, Cuburu N, Blomquist M, Li BL, Czerkinsky C, Holmgren J. Sun JB, et al. Scand J Immunol. 2006 Sep;64(3):251-9. doi: 10.1111/j.1365-3083.2006.01823.x. Scand J Immunol. 2006. PMID: 16918694 - Antigen-specific CD4+ T cells that survive after the induction of peripheral tolerance possess an intrinsic lymphokine production defect.
Pape KA, Khoruts A, Ingulli E, Mondino A, Merica R, Jenkins MK. Pape KA, et al. Novartis Found Symp. 1998;215:103-13; discussion 113-9, 186-90. doi: 10.1002/9780470515525.ch8. Novartis Found Symp. 1998. PMID: 9760574 Review. - Controlling autoreactivity of CD4 T cells by local tolerance induction.
Förster I. Förster I. Dev Immunol. 1998;6(1-2):89-94. doi: 10.1155/1998/83953. Dev Immunol. 1998. PMID: 9716909 Free PMC article. Review. No abstract available.
Cited by
- BATF represses BIM to sustain tolerant T cells in the periphery.
Titcombe PJ, Silva Morales M, Zhang N, Mueller DL. Titcombe PJ, et al. J Exp Med. 2023 Dec 4;220(12):e20230183. doi: 10.1084/jem.20230183. Epub 2023 Oct 20. J Exp Med. 2023. PMID: 37862030 Free PMC article. - Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses.
Tremain AC, Wallace RP, Lorentz KM, Thornley TB, Antane JT, Raczy MR, Reda JW, Alpar AT, Slezak AJ, Watkins EA, Maulloo CD, Budina E, Solanki A, Nguyen M, Bischoff DJ, Harrington JL, Mishra R, Conley GP, Marlin R, Dereuddre-Bosquet N, Gallouët AS, LeGrand R, Wilson DS, Kontos S, Hubbell JA. Tremain AC, et al. Nat Biomed Eng. 2023 Sep;7(9):1142-1155. doi: 10.1038/s41551-023-01086-2. Epub 2023 Sep 7. Nat Biomed Eng. 2023. PMID: 37679570 - NDRG1 is induced by antigen-receptor signaling but dispensable for B and T cell self-tolerance.
Hodgson R, Xu X, Anzilotti C, Deobagkar-Lele M, Crockford TL, Kepple JD, Cawthorne E, Bhandari A, Cebrian-Serrano A, Wilcock MJ, Davies B, Cornall RJ, Bull KR. Hodgson R, et al. Commun Biol. 2022 Nov 10;5(1):1216. doi: 10.1038/s42003-022-04118-w. Commun Biol. 2022. PMID: 36357486 Free PMC article. - Conversion of Anergic T Cells Into Foxp3- IL-10+ Regulatory T Cells by a Second Antigen Stimulus In Vivo.
Thomann AS, Schneider T, Cyran L, Eckert IN, Kerstan A, Lutz MB. Thomann AS, et al. Front Immunol. 2021 Jun 25;12:704578. doi: 10.3389/fimmu.2021.704578. eCollection 2021. Front Immunol. 2021. PMID: 34249012 Free PMC article. - Cbl-b deficiency prevents functional but not phenotypic T cell anergy.
Nguyen TTT, Wang ZE, Shen L, Schroeder A, Eckalbar W, Weiss A. Nguyen TTT, et al. J Exp Med. 2021 Jul 5;218(7):e20202477. doi: 10.1084/jem.20202477. Epub 2021 May 11. J Exp Med. 2021. PMID: 33974042 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials